Active targeting and specific drug delivery to parenchymal liver cells is a promising strategy to treat various liver disorders. Here. we modified synthetic lipid-based nanoparticles with targeting peptides derived from the hepatitis B virus large envelope protein (HBVpreS) to specifically target the sodium-taurocholate cotransporting polypeptide (NTCP; SLC10A1) on the sinusoidal memb... https://www.roneverhart.com/